Publications by authors named "Yoko Machida"

Claim this Profile
E
Early severe immune-related pneumonitis, hepatitis, and agranulocytosis with radiographic response in sarcomatoid malignant pleural mesothelioma treated with nivolumab and ipilimumab: a case report highlighting dual liver biopsies and rechallenge decision-making.
Tomohiro Oba, Katsuhiro Itogawa, Yoko Machida, Yuji Ono, Yuho Morita

Ther Adv Med Oncol· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[A case of antisynthetase syndrome with anti-EJ antibody complicated by pericarditis].
Kumiko Hayashi, Yoko Machida, Yuki Katayama, Hiroaki Yokote, Kazuyuki Saito

Rinsho Shinkeigaku· January 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Small interfering RNA delivery into the liver by cationic cholesterol derivative-based liposomes.
Yoshiyuki Hattori, Yoko Machida, Maho Honda, Nozomi Takeuchi, Yuki Yoshiike

J Liposome Res· December 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Blocking acid-sensing ion channel 1 alleviates Huntington's disease pathology via an ubiquitin-proteasome system-dependent mechanism.
Hon Kit Wong, Peter O Bauer, Masaru Kurosawa, Anand Goswami, Chika Washizu, Yoko Machida

Hum Mol Genet· October 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
RNA-binding protein TLS is a major nuclear aggregate-interacting protein in huntingtin exon 1 with expanded polyglutamine-expressing cells.
Hiroshi Doi, Kazumasa Okamura, Peter O Bauer, Yoshiaki Furukawa, Hideaki Shimizu, Yoko Machida

J Biol Chem· March 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Sodium channel beta4 subunit: down-regulation and possible involvement in neuritic degeneration in Huntington's disease transgenic mice.
Fumitaka Oyama, Haruko Miyazaki, Naoaki Sakamoto, Celine Becquet, Yoko Machida

J Neurochem· July 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
rAAV-mediated shRNA ameliorated neuropathology in Huntington disease model mouse.
Yoko Machida, Takashi Okada, Masaru Kurosawa, Fumitaka Oyama, Keiya Ozawa

Biochem Biophys Res Commun· April 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A novel therapeutic strategy for polyglutamine diseases by stabilizing aggregation-prone proteins with small molecules.
Motomasa Tanaka, Yoko Machida, Nobuyuki Nukina

J Mol Med (Berl)· May 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Decreased expression of hypothalamic neuropeptides in Huntington disease transgenic mice with expanded polyglutamine-EGFP fluorescent aggregates.
Svetlana Kotliarova, Nihar R Jana, Naoaki Sakamoto, Masaru Kurosawa, Haruko Miyazaki, Yoko Machida

J Neurochem· May 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Identification of ubiquitin-interacting proteins in purified polyglutamine aggregates.
Hiroshi Doi, Kenichi Mitsui, Masaru Kurosawa, Yoko Machida, Yoshiyuki Kuroiwa

FEBS Lett· July 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Trehalose alleviates polyglutamine-mediated pathology in a mouse model of Huntington disease.
Motomasa Tanaka, Yoko Machida, Sanyong Niu, Tetsurou Ikeda, Nihar R Jana

Nat Med· February 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Expansion of polyglutamine induces the formation of quasi-aggregate in the early stage of protein fibrillization.
Motomasa Tanaka, Yoko Machida, Yukihiro Nishikawa, Takumi Akagi, Tsutomu Hashikawa

J Biol Chem· September 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The effects of aggregation-inducing motifs on amyloid formation of model proteins related to neurodegenerative diseases.
Motomasa Tanaka, Yoko Machida, Yukihiro Nishikawa, Takumi Akagi, Isao Morishima

Biochemistry· August 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis